Point72 Asset Management L.P. Takes Position in Chemed Co. (NYSE:CHE)

Point72 Asset Management L.P. bought a new position in shares of Chemed Co. (NYSE:CHE - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 103,032 shares of the company's stock, valued at approximately $54,587,000. Point72 Asset Management L.P. owned approximately 0.68% of Chemed at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. increased its position in shares of Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares during the period. Atala Financial Inc bought a new position in Chemed during the fourth quarter valued at about $29,000. CBIZ Investment Advisory Services LLC grew its holdings in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after acquiring an additional 22 shares during the period. Trust Co. of Vermont bought a new stake in Chemed in the fourth quarter worth about $34,000. Finally, Tortoise Investment Management LLC lifted its holdings in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after acquiring an additional 34 shares during the last quarter. Institutional investors own 95.85% of the company's stock.

Insider Buying and Selling at Chemed

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of the firm's stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total transaction of $866,790.00. Following the completion of the sale, the executive vice president now directly owns 16,127 shares in the company, valued at approximately $9,319,148.22. This trade represents a 8.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. This represents a 1.91% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,000 shares of company stock valued at $3,534,135 in the last three months. 3.29% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

CHE has been the topic of several recent research reports. Royal Bank of Canada lifted their price objective on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Chemed Stock Up 2.2%

NYSE:CHE opened at $565.83 on Friday. The stock has a fifty day simple moving average of $586.60 and a 200 day simple moving average of $564.22. The firm has a market capitalization of $8.28 billion, a price-to-earnings ratio of 28.59, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same period last year, the company posted $5.20 earnings per share. The business's revenue for the quarter was up 9.8% on a year-over-year basis. Equities analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.